Industrial societies have developed a way of life that is increasingly dependent on artefacts produced from chemicals. The benefits that man has derived from the use of these artefacts are abundant and include the control of disease, increased agricultural production, and improved quality of life. It is only in recent years, however, that the price that society has paid in terms of damage to human health has become the subject of concern, as is evidenced by the many chemicals of unknown biological activity introduced into manufacture during the early decades of this century.
A major aspect of concern about the effects of chemicals on man centres on their carcinogenicity. By definition, human carcinogens can be identified only by epidemiological studies in man, a procedure that is manifestly too late to prevent suffering. Attention has thus been concentrated on developing laboratory methods based on parameters other than human cancer, which are nevertheless capable of identifying chemicals with biological activity classifying them as candidate human carcinogens.
These laboratory models include both in-vitro or "short-term" tests for carcinogenicity and the more conventional chronic animal studies.
Laboratory models of this type have certain characteristics that define their performance and thus their utility in identifying carcinogens and their potential effects in man. This paper discusses the predicitivity and reliability of short-term tests and their ability to assess carcinogenic potency. Similar characteristics for animal carcinogenicity studies are also discussed.
Short-term tests
During the past few years, a large variety of shortterm tests has been described. Most of these are based on mutation as an end-point and have contributed substantially to the theory that cancer is caused by somatic mutation. Others, however, are based on various end-points (some of which may also *Paper given at the XIX Congress on Occupational Health, Dubrovnik, 25-30 September 1978. 1 be due to mutation) including biochemical changes, behaviour of tissues exposed to carcinogens, chemical reactivity, and alterations in behaviour of cells in culture. In most cases there are few data on which to judge the merits of the tests, but the salmonella plate test' and the cell transformation assay2 are among the most extensively studied.
The salmonella plate test, which is extensively used for screening for carcinogens, is based on the induction of mutations in strains of Salmonella typhimurium using a system which incorporates liver enzymes to metabolise the chemical under test (fig 1) . The cell transformation assay uses BHK21 cells in culture which are "transformed," allowing growth in agar, by carcinogens. A metabolic system is also incorporated (fig 2) . Target cell Assay system-Hexamethylphosphoramide is a potent rat carcinogen producing tumours of the nasal sinuses in rats exposed to 20 ppb by inhalation.'0 As this was the first indication that this chemical was carcinogenic, it immediately raised the question of which of its analogues would also be carcinogenic. Repeated testing using the salmonella plate test resulted in a variable response, positive results only being obtained in about 30% of the tests.8 11 The response in the cell transformation assay was much more consistent and, as a consequence, it was possible to establish that the structural feature responsible for the carcinogenic activity was probably related to the N-dimethylamino function. The 16 Number of cells-When the number of cells plated is altered, the mutant yield also changes, but not in proportion to the change in cell number. Thus a reduction in the number of salmonella added to the plate to 10% reduces the mutant yield produced by N-nitrosomorpholine, N-nitroso-N'-methylpiperazine, N-nitrosopiperidine, and N-nitrosopyrrolidine to 65, 55, 32, and 25 % respectively of the values obtained with 108 bacteria.9
Oxygen content-Assays are normally conducted under aerobic conditions but different results can be obtained by using anaerobic incubation. Azathioprine, negative in the standard assay, is positive if incubated for 14 Metabolic activation system The S9 mix currently used is somewhat arbitrary, and it is not surprising that it is a principal, if not the major, source of variability in the response of those chemicals that require metabolic activation. The following are among the factors so far identified:
Inducers-"Aroclor" 1254, 3-methylcholanthrene, and phenobarbitone are the commonly used inducing agents. Their effects on the enzymes induced in the liver, or other organs, differ and hence they alter the response observed in these tests. 20 Diet-Rats fed a lipotrope-deficient diet were used to provide liver for preparation of S9 mix21 which resulted in a reduction in the colonies produced by aflatoxin B, in the salmonella plate test. Even when mixed with normal S9, a reduced response was observed, despite the fact that rats on lipotropedeficient diets are more susceptible to the effects of aflatoxin Bi carcinogenesis.
Organ-Different organs have different activities and specificities of metabolising enzymes, and this is reflected in the variable response observed when S9 is prepared from various organs.22 23 Species-Acetylaminofluorene is claimed to be non-carcinogenic in cotton rats but is a potent carcinogen in rats. S9 mix derived from cotton rats is, however, much more efficient in producing a positive response than that from rats.24 This effect has also been observed in S9 derived from rats and mice25 26 with vinylidene dichloride. Enhanced response-The addition of the nonmutagenic norharman to the medium resulted in a pronounced increase in the response.3' Similarly, azobenzene will greatly stimulate the response of butter yellow,28 presumably by inhibiting or saturating detoxication pathways. Another way in which enhanced responses are seen is when chemicals give positive results because of potent mutagenic impurities32-for instance, the positive result obtainable with trichloroethylene, caused by the presence of stabilisers, in the salmonella plate assay. 33 Diminished response-If a mixture containing a very toxic chemical is tested in an in-vitro test the toxicity can obscure the positive result (table 4) . Cysteine, when added to the culture medium, can reduce or abolish the positive response of a number of otherwise mutagenic chemicals. 18 Unexplained response-Ashby and Styles13 describe a number of changes in the response of the salmonella plate test (for example, changes in response to safrole, dimethylnitrosamine, and hexamethylphosphoramide) which are as yet unexplained.
The phenomenon of "phenotypic reversion" is another example of an unexplained result (Longstaff Purchase "Mechanism" false-negatives-As more data on the mode of action of carcinogens are produced, it is becoming clear that many of them are carcinogenic as a result of one of several mechanisms other than mutation. These "epigenetic" carcinogens will not always be detected by a mutation-based assay.7 Examples include chemicals that act by interfering with the hormone balance (diethylstilbestrol, oestrogens, goitrogens, and antithyroid agents), those which produce tumours as a secondary response to tissue damage (alcohol-induced liver tumours in man, diethylene glycol-induced bladder tumours in rats37), and a variety of others where the mechanism of action is unknown (chloroform, carbon tetrachloride, dieldrin, phenobarbitone, and saccharin).
"Activation" false-negative-As has been pointed out in the discussion on potency, the metabolic competence of the S9 mix may differ considerably from the situation in the whole animal, and the spatial relationship between the site of production of active metabolites and the molecular target may be very different. A simple example of this is cycasin, which is carcinogenic in rats but negative in the salmonella plate test because it requires /Bglucosidase from gut bacteria to produce the active metabolite, methylazoxymethanol, which is the proximate carcinogen. Although cycasin is converted to the active metabolite in rats, this does not occur with the standard S9 mix but requires addition of ,B-glucosidase. Another example of a carcinogenic compound that is often negative, but with a putative metabolite that is positive in the salmonella plate test, is safrole.
False-positive results (or positive results obtained on mammalian non-carcinogens)
"Technical" false-positive-Any characteristic of the test protocol that results in a positive may be described as an artefact or technical false-positive. A rather facetious example would be histidine or any histidine analogue that supported growth of the indicator organism. The more serious example is that provided by phenotypic reversion mentioned earlier.
"Mechanism" false-positives-The simplicity of the in-vitro models in comparison with the in-vivo condition suggests that there may be chemicals positive in the in-vitro tests that do not produce results in vivo, because, for example, immunological surveillance or DNA repair reverse the lesion. I know of no example of this type.
"Activation"false-positives-There are two distinct mechanisms by which the metabolic system may produce false-positive results. In the first the chemical, or its metabolite, is so reactive that it irreversibly binds to other macromolecules in vivo before the ultimate metabolite can react with the DNA. Examples include dichlorvos, which is so rapidly hydrolised that no systemic genetic effects are produced. A parallel example (which is not entirely relevant) is 3-propiolactone, which is positive in microbial mutagenicity assays, but does not produce systemic genetic effects,38 although it is carcinogenic at the site of application. The second type occurs when a chemical is metabolised to an electrophilic product not seen in vivo and not producing carcinogenic effects. The 5,6-epoxide of 7,1 2-dimethylbenz(a)anthracene is positive in the salmonella plate test but probably non-carcinogenic. Similarly, the 4,5-epoxide of benzo(a)pyrene is strongly positive in TA1537 but does not produce skin tumours in mice.39 (±) Trans-7fl,8-dihydrodiol9a,lOa-epoxy-7,8,9,10-tetrahydro benzo(a)pyrene is another positive material that is inactive as a complete carcinogen or initiator40 in mouse skin (although it produces benign pulmonary tumours in newborn mice). An excess of nitroreductases in S typhimurium which are less active in vivo may also provide false-positive results for some nitrofurans.1 "Incorrect".false-positives-In many cases animal carcinogenicity data are of such a poor standard that the classification of the chemical as a non-carcinogen is incorrect. Thus The numbers refer to the number of compounds that have been tested in at least two species with the result specified at the head of th2 column.
monograph did not provide an opinion on the carcinogenicity of a compound in at least two species, that compound was omitted.) The problem with that series is that the compounds have been selected because of suspicion of carcinogenicity; hence a requirement for a broader selection led to the use of the third source, "Survey of compounds which have been tested for carcinogenicity." Compounds were selected, using the index, which had data reported in at least two species. The original publications were then consulted and only those that were considered adequate accepted.
Data on carcinogenicity were available on 207 compounds which had been tested in two species (usually rat and mouse). Ninety-one compounds were positive in both species, 83 negative in all species, and 33 had differences between species (table 5) . Thus a compound that was carcinogenic in one species had about a 75 % chance of being carcinogenic in the second. It 
Conclusion
Whatever model is used as a screening procedure for carcinogenicity, there are apparently shortcomings and problems associated with its use. The purpose of using screening tests is to predict potential human carcinogenicity before exposure of man results in the development of cancer. The results of validation of short-term tests and of correlations between mammalian carcinogenicity data from different species lead to the conclusion that a positive result in any single-test system, in the presence of negative results from several other tests, gives a lower predictivity of activity in man. In the case of shortterm tests this predictivity is considerably enhanced when two-test systems are used, and the results are the same. Thus positive data in more than one test system provides an increased confidence in the predictivity of the result.
As we have seen, the qualitative and quantitative results from in-vitro and in-vivo tests are subject to considerable change when certain parameters of the I test are altered. In some cases the conditions of the test may have to be very precisely determined before a positive result is obtained. In others, such as in the case of powerful alkylating agents in short-term tests or nitrosamines in mammals, the conditions of testing are not critical, a positive being obtained very easily. This variability in the "ruggedness" of the data should be used in extrapolation to man. Aflatoxin B1, which is positive in many in-vitro tests and carcinogenic to rats, pigs, trout, ducks, and other species, would thus have a high probability of being carcinogenic to man. Trichloroethylene, which is negative in a variety of in-vitro tests, is non-carcinogenic in rats. The liver tumours produced in mice (if they are not due to stabilisers) must be considered with the negative data. It seems much less likely that it will be carcinogenic in an untested species (that is, man).
Ultimately the only way of showing that a chemical is a human carcinogen is by observing occupationally associated increases in cancer incidence in working populations. Epidemiological evidence of this type would obviously take precedence over negative results from laboratory studies. The converse, however, does not give such a clear-cut conclusion. Negative epidemiology is often not sufficiently convincing to define non-carcinogenicity of a chemical, because of the numerous difficulties inherent in epidemiological studies of working populations (such as the length of the observation period and the difficulties in obtaining a sufficiently large group of works with complete follow-up and records of exposure levels).
Negative studies are particularly unconvincing in the face of positive data from in-vitro or conventional laboratory studies, even though, as explained above, direct extrapolation from laboratory models to man is bound to contain inaccuracies. The use of several laboratory systems allows a qualitative assessment of the accuracy of the extrapolation. When all systems agree, greater confidence can be placed in the extrapolation than when there are substantial disagreements between the results from different laboratory models; in the latter case accurate extrapolation will have to await an understanding of why the differences occur and which result is most relevant to man.
